MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED CYTOTOXIC T-LYMPHOCYTE RESPONSES IN HORSES INFECTED WITH EQUINE HERPESVIRUS-1

被引:73
作者
ALLEN, G [1 ]
YEARGAN, M [1 ]
COSTA, LRR [1 ]
CROSS, R [1 ]
机构
[1] UNIV KENTUCKY, DEPT MICROBIOL & IMMUNOL, LEXINGTON, KY 40546 USA
关键词
D O I
10.1128/JVI.69.1.606-612.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
An experimental system that permits sensitive and reproducible detection of equine herpesvirus 1 (EHV-1)-specific cytotoxic T-lymphocyte (CTL) activity in the horse was developed. Peripheral blood mononuclear cells (PBMC) collected from immune horses were restimulated in vitro by culture with live EHV-1. Cytotoxic activity against virus-infected, pokeweed mitogen-stimulated lymphoblast targets was assessed in a 4-h Cr-51 release assay. The optimal conditions for in vitro stimulation of equine memory CTLs and for preparation of EHV-l-infected target cells expressing viral antigens were systematically identified by individually testing the effects of variations in responder cell concentration, culture medium composition, serum type, incubation time, antigen form, and exogenous mediator content. By using this optimized system for generation and assay of equine CTLs, the development of EHV-1-specific cytotoxic responses in 12 horses was evaluated after experimental viral infection. CTLs with the capacity for killing EHV-1-infecfed target cells were detected in equine PBMC as early as 1 week postinfection, reached maximal levels by 2 to 3 weeks, and remained detectable for a year after infection. Equine effector cells mediating lysis of EIN-l-infected targets were predominantly CD8(+) T lymphocytes, and the cytotoxicity was specific for virus and restricted by major histocompatibility complex class I molecules. The results define a reliable and convenient experimental system for generation and assay of EHV-1 CTLs which can now be used for more-detailed characterization of the equine CTL response to infection by this herpesvirus pathogen.
引用
收藏
页码:606 / 612
页数:7
相关论文
共 47 条
[1]  
Allen G P, 1986, Prog Vet Microbiol Immunol, V2, P78
[2]   THE EQUINE-VIROLOGY-RESEARCH-FOUNDATION - A VIEW FROM ABROAD [J].
ALLEN, GP .
EQUINE VETERINARY JOURNAL, 1994, 26 (04) :259-262
[3]  
ALLEN GP, 1992, EQUINE INFECTIOUS DI, V6, P181
[4]  
ANTCZAK DF, 1986, ANIM GENET, V17, P363
[5]  
ANTCZAK DF, 1992, EQUINE INFECTIOUS DI, V6, P99
[6]   IDENTIFICATION AND GENETICS OF HORSE LYMPHOCYTE ALLOANTIGENS [J].
BAILEY, E .
IMMUNOGENETICS, 1980, 11 (05) :499-506
[7]  
BAILEY E, 1983, ANIM BLOOD GROUPS BI, V14, P201
[8]  
Bryans J T, 1986, Rev Sci Tech, V5, P837, DOI 10.20506/rst.5.4.273
[9]  
BRYANS JT, 1977, J EQUINE MED SURG, V1, P20
[10]  
BRYANS JT, 1969, J AM VET MED ASSOC, V155, P294